SMO expression level correlates with overall survival in patients with malignant pleural mesothelioma

BACKGROUND: Malignant mesothelioma is an aggressive, treatment-resistant tumor arising from mesothelium of pleura, peritoneum and pericardium. Despite current combined regimen, its prognosis remains dismal, calling for more effective targeted therapies. We investigated whether aberrant Hh activation...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yi, He, Jianxing, Zhang, Fang, Li, Hui, Yue, Dongsheng, Wang, Changli, Jablons, David M, He, Biao, Lui, Natalie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3622612/
https://www.ncbi.nlm.nih.gov/pubmed/23379358
http://dx.doi.org/10.1186/1756-9966-32-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3622612/
https://www.ncbi.nlm.nih.gov/pubmed/23379358
http://dx.doi.org/10.1186/1756-9966-32-7

Ejemplares similares